20.02.2013 Views

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

Drug Targeting Organ-Specific Strategies

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

238 9 Tumour Vasculature <strong>Targeting</strong><br />

loss of growth potential. Addition of low concentrations of recombinant or purified growth<br />

factors such as FGF-2 will increase the number of possible passages to 10–12. These limited<br />

subculture possibilities make repeated isolations necessary, thereby introducing significant<br />

variation in the endothelial cell source. To circumvent these drawbacks, it is possible to immortalize<br />

endothelial cells with viral oncogenes such as simian virus-40 large T antigen.<br />

Transfection of endothelial cells with a DNA construct containing the gene for this molecule<br />

can result in cell lines that can be subcultured for over 60 passages. Examples of such cell<br />

lines are HMEC-1 [37], EA.hy926 [38], ECL4n [39], and EvL [40]. The major problem with<br />

these immortalized endothelial cells is, however, that they are not genetically stable, resulting<br />

in loss of phenotypic and functional characteristics and functional resemblance to their in<br />

vivo counterparts. Of note, many endothelial cell lines can be cultured on plastic tissue-culture<br />

material, without being dependent on integrin signalling via ECM molecules for growth<br />

and survival. Careful interpretation of results obtained with these cell lines is necessary.<br />

Endothelial cells can also be prepared from tissue from other species. Capillary endothelial<br />

cells of bovine origin are used quite frequently, because these cells are rather sensitive to<br />

treatment with angiogenesis inhibitors such as angiostatin and endostatin (Griffioen et al.,<br />

unpublished results). It should be noted however, that species-dependent responses to drugs<br />

can occur.<br />

9.2.2 Functional Assays with Endothelial Cells<br />

Angiogenesis is a multi-step process, depending on activation, migration, proliferation and<br />

differentiation of endothelial cells, and all of these stages in the cascade can be studied independently.<br />

9.2.2.1 Cell Growth Assays<br />

Proliferation of endothelial cells can be studied using various assays. Since the cell cycle potential<br />

of endothelial cells is low, with cell doubling times of sometimes over 35 h, cell counting<br />

is a time-consuming and insensitive method of assessing cell growth. A much better way<br />

to determine proliferation is by the measurement of [ 3 H]-thymidine incorporation [41,42].<br />

Alternative assays for the study of endothelial cell proliferation and other mechanisms of cell<br />

activation that do not involve the S-phase of the cell cycle, are based on colorimetric systems<br />

which measure mitochondrial activity. Furthermore, proliferation of endothelial cells can be<br />

analysed by DNA profiling, for example by flow cytometric analysis of cells in G0/G1 phase<br />

(2n DNA), cells in G2/M phase (4n DNA) and cells in S phase (2 < n < 4) after permeabilization<br />

and staining with propidium iodide. In addition, proliferation can be quantified by<br />

determination of cell cycle-dependent expression of molecules such as proliferating cell nuclear<br />

antigen (PCNA) [43] or Ki-67 [44].<br />

The number of cells present depends on the level of cell growth and cell death. Therefore,<br />

detection of cell death is a commonly used approach to average cell growth. Apoptosis induction<br />

can be studied most easily by detection of subdiploid cells or analysis of DNA degradation<br />

profiles on the flow cytometer after DNA extraction and propidium iodide staining.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!